Advertisement

Perspectives and Future Directions

  • Stephan D. VossEmail author
  • Kieran McHugh
Chapter
Part of the Pediatric Oncology book series (PEDIATRICO)

Abstract

Over the past two decades, survival rates in pediatric oncology have continued to increase; more than 80% of children diagnosed with cancer are now alive at 5 years from the time of diagnosis. New treatment paradigms are emerging, accelerated by an increased understanding of the molecular processes underlying the growth and development of specific childhood cancers. Our responsibility as pediatric radiologists is to complement these efforts and help to bring the best new therapies quickly into clinical practice. This text has focused on the fundamentals of imaging that every child with a new or treated malignancy receives, and provides a comprehensive update on new advances in diagnostic imaging as they relate to pediatric oncology.

Keywords

Cancer survival Chest CT Cancer diagnosis Structured reporting Survivorship Novel therapeutics Drug development 

References

  1. 1.
    Adamson PC. Improving the outcome for children with cancer: development of targeted new agents. CA Cancer J Clin. 2015;65:212–20.CrossRefGoogle Scholar
  2. 2.
    Allen CE, Laetsch TW, Mody R, et al. Target and agent prioritization for the Children’s Oncology Group-National Cancer Institute Pediatric MATCH trial. J Natl Cancer Inst. 2017;109(5)Google Scholar
  3. 3.
    McHugh K, Pritchard J. Problems in the imaging of three common paediatric solid tumours. Eur J Radiol. 2001;37:72–8.CrossRefGoogle Scholar
  4. 4.
    McCarville MB, Lederman HM, Santana VM, et al. Distinguishing benign from malignant pulmonary nodules with helical chest CT in children with malignant solid tumors. Radiology. 2006;239:514–20.CrossRefGoogle Scholar
  5. 5.
    Vaarwerk B, Bisogno G, McHugh K, Brisse HJ, Morosi C, Corradini N, Jenney M, Orbach D, Chisholm JC, Ferrari A, Zanetti I, De Salvo GL, van Rijn RR, Merks JHM, on behalf of the EpSSG Radiology Group. Indeterminate pulmonary nodules at diagnosis in rhabdomyosarcoma: are they clinically significant? A report from the European Paediatric Soft tissue sarcoma Study Group. 2019. J Clin Oncol  https://doi.org/10.1200/JCO.18.01535, in press.
  6. 6.
    Pritchard-Jones K, Graf N, van Tinteren H, et al. Evidence for a delay in diagnosis of Wilms’ tumour in the UK compared with Germany: implications for primary care for children. Arch Dis Child. 2016;101:417–20.CrossRefGoogle Scholar
  7. 7.
    Schwartz LH, Panicek DM, Berk AR, et al. Improving communication of diagnostic radiology findings through structured reporting. Radiology. 2011;260:174–81.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Boston Children’s HospitalHarvard Medical SchoolBostonUSA
  2. 2.Great Ormond Street Hospital for ChildrenLondonUK

Personalised recommendations